Global biopharmaceutical company, AbbVie, have today announced they will further expand their medical device manufacturing facility in Ballytivnan, Sligo, Ireland. Furthermore, over the next four years, they plan to create 50 new highly-skilled jobs focused on devices that deliver AbbVie’s medicines to patients around the world.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
The company’s manufacturing site in Ballytivnan currently produces drug delivery devices, including a pen-style injector that is used by patients around the world who use AbbVie’s treatment indicated for a range of auto-immune conditions. The site is AbbVie’s ‘centre of excellence’ for medical device manufacture, precision engineering, plastics moulding and metrology.
Site Director at Ballytivnan for AbbVie, Joe Kumor said, “For more than 40 years, our expert team in Ireland has been committed to serving patients around the world. The IDA’s support allows us to build our capabilities and help ensure that patients of AbbVie medicines continue to have access to best-in-class medical devices for their treatment.”
Written by Robert McHugh, on 29th June 2015.